^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    IONIS-AR-2.5Rx

    i
    Other names: IONIS-AR-2.5Rx, AZD5312, ISIS-AZ1Rx, ISIS 560131, ISIS-ARRx, ARRx, ISIS AZ1Rx, ISIS-AR-2.5Rx, ISIS-560131, IONIS AR 2.5Rx, AZD 5312, ISIS ARRX, IONISARRx, SR063
    Associations

    News

    Trials
    Company:
    Flamingo Therapeutics, Ionis, Suzhou Ribo
    Drug class:
    Androgen receptor antagonist
    Related drugs:
    Associations

    News

    Trials
    11ms
    ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer (clinicaltrials.gov)
    P1, N=9, Terminated, University of Michigan Rogel Cancer Center | Phase classification: P1/2 --> P1
    Phase classification • Combination therapy • Metastases
    |
    Xtandi (enzalutamide) • IONIS-AR-2.5Rx